UK Interstitial Cystitis Market Analysis


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2569

  • Format: PPT, PDF

UK Interstitial Cystitis Therapeutics Market: Segmented by Route of Administration, Drug Class, Innovative Therapies, and Distribution Channels – Size, Share, Impact, Growth, Trends, and Forecasts (2019 – 2028)

Published Date: June 2021

SKU: 2569 Categories: ,

Report Overview

The UK Interstitial Cystitis (IC) Therapeutics market size stood at around USD 0.075 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

According to the Interstitial Cystitis Association (ICA), Interstitial cystitis (IC), is a bladder condition that usually consists of multiple symptoms. Interstitial Cystitis also called Painful Bladder Syndrome, is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. The pain ranges from mild discomfort to severe levels. With IC, these signals get mixed up and then patients feel the need to urinate more often and with smaller volumes of urine than most people.

About 90% of those who are affected are women. Patients of all ages can be affected, although women in their 20s and 40s are the most typically affected. The most commonly used methods to diagnose IC include physical examination, ultrasound/pelvic imaging, laboratory tests such as urinalysis, culture, cytology, potassium sensitivity test, etc. Although there is no cure, yet off-label medications and other therapies may offer some relief.

Market Growth Drivers

As there is a lack of approved drugs for the better IC treatment but only a few medications and other therapies may offer some relief such as has these two approved drugs are currently available in the UK, ELMIRON and RIMSO-50 (dimethyl sulfoxide) can be expected that they would augment the market during the forecast period.

So, there is a huge market potential for the newly approved drugs in this niche market segment for the effective cure of interstitial cystitis in the UK.

Studies suggested that females are 9 times more likely to be diagnosed with IC/PBS compared to males. Thus, the female gender is the most definitive risk factor for developing IC/PBS, hence this will propel the market during the forecast period.

1. UK Interstitial Cystitis Therapeutics Market Overview………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………
A. Lack of Approved Drugs and the Opportunities
B. Introduction of Innovative Drugs by Major Players
C. Females More Responsible to Propels the Market Growth
D. Increasing Awareness of Interstitial Cystitis
3. Epidemiology of UK Interstitial Cystitis……………………………………….
A. Age-specific Diagnosed Prevalent Population
B. Gender-specific Diagnosed Prevalent Population
C. Severity-based Diagnosed Prevalent Population
D. Type-specific Diagnosed Prevalent Population
E. Total Diagnosed Prevalent Population
4. Interstitial Cystitis Therapeutics Market Segmentation……………………..
A. By Route of Administration
I. Oral
II. Intravesicular
III. Others
B. By Drug class
I. Over The Counter Drugs
II. Narcotic Drugs
III. Non-Narcotic Drugs
IV. Antidepressants
V. Bladder Instillations
VI. Immunosuppressants
VII. Selective Serotonin Reuptake Inhibitors (SSRIs)
VIII. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
IX. Others
C. By Innovative Therapies
I. Marketed Drugs
II. Emerging Drugs
D. By Distribution Channels
I. Retail Pharmacies
II. Drug stores
III. Hospitals Pharmacies
IV. Online Pharmacies
5. Interstitial Cystitis Major Drugs Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Janssen Company overview, Product & Services, Strategies & Financials
B. Mylan Company overview, Product & Services, Strategies & Financials
C. Kyorin Company, Product & Services, Strategies & Financials
D. Lipella Company, Product & Services, Strategies & Financials
E. UCB Company, Product & Services, Strategies & Financials
F. Astellas Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………..
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………
A. New Trends and Development of Interstitial Cystitis Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Route of Administration:

According to the route of administration, the Interstitial Cystitis treatment market is segregated into

  • Oral
  • Intravesicular
  • Others

Out of these, the oral route is the most preferred route because of ease of use and convenience and the drugs taken by the oral route are more easily accessible and quite economical as compared to that of the intravesicular one.

By Drug Class:

On the basis of drug class, the Interstitial Cystitis treatment market can be segmented into

  • Over-the-counter drugs (Aspirin, Acetaminophen, NSAIDs, etc.)
  • Narcotic drugs (Codeine, Oxycodone, Tapentadol, etc.)
  • Non-narcotic drugs (Pyridium, Topical Medicines, Lidocaine Patch, etc.)
  • Antidepressants
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIS)
  • Bladder Instillations
  • Immunosuppressants
  • Others

By Innovative Therapies:

To date, there are only two approved marketed therapies to treat interstitial cystitis such as

  • Oral Elmiron (pentosan polysulfate sodium) of Janssen Pharmaceuticals
  • Intravesical RIMSO-50 (dimethyl sulfoxide) of Mylan Pharmaceuticals

Some of the emerging drugs may include,

  • KRP-116D of Kyorin Pharmaceuticals
  • Certolizumab pegol (Cimzia) of UCB Pharma
  • LP-08 of Lipella Pharmaceuticals
  • ASP-6294 is a Nerve Growth Factor (NGF) neutralization antibody developed by Astellas Pharma.

By Distribution Channel:

Based on the distribution channel, the Interstitial Cystitis treatment market is classified into

  • Retail pharmacies
  • Drug stores
  • Hospital pharmacies
  • Online pharmacies.

Due to the COVID-19 pandemic outbreak, the emergence of many e-pharmacies collaborating with giant-tech, online detailing boosts up the market share as well and anticipated to emerge as the fastest-growing segment in the market. The convenience of drugs, easy availability, and others are augmenting the growth of online pharmacies during the forecast period.

Top Major Players

The UK Interstitial Cystitis Market is a niche segment yet highly competitive, and the prominent players in the UK market have adopted various strategies to garner maximum market share. Majorly these include the application of innovative novel technologies to make highly effective drugs, drugs to be administered by different routes such as intravesicular for the drug installation directly into the bladder following insertion of a catheter into the urethra. Some of the major players which are currently dominating the market are Janssen Pharmaceuticals, Mylan Pharmaceuticals, Kyorin Pharmaceuticals, UCB Pharma, Lipella Pharmaceuticals, Astellas Pharma, etc.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements